WCN26-7108 The autophagy enhancer MSL-7 prevents renal fibrosis by activating the autophagy-lysosomal pathway and improving lysosomal stress in a mouse model of CKD

Read full text Summarise with VIRAT
Authors: Jina Lee, Seong Woo Lee, Hun‐Jun Park, Su Bin Lee, Myung-Shik Lee, Ji-Hye Lee, Eun Young Lee
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Autophagy is a fundamental mechanism that maintains cellular homeostasis by degrading and recycling damaged organelles and cellular components. However, in chronic kidney disease (CKD), the autophagy-lysosomal pathway is suppressed or functionally impaired, leading to the accumulation of damaged mitochondria and proteins within cells, which induces oxidative stress and inflammatory responses, ultimately accelerating tubular injury and renal dysfunction. Transcription Factor EB (TFEB), a key regulator of autophagy and lysosomal biogenesis, is dysregulated in CKD, contributing to impaired autophagic flux and disease progression.

Fields of Study & Subjects

Autophagy in Disease and Therapy Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104515–104515
Publication date
25 March 2026
Language
EN